1202033-17-7

Basic information

• Product Name: (2S,2'S,3S,3'S)-BIBOP
• Synonyms: (2S,2'S,3S,3'S)-BIBOP;(2S,2'S,3S,3'S)-3,3'-di-tert-butyl-2,2',3,3'-tetrahydro-2,2'-bibenzo[d][1,3]oxaphosphole;(2S,2'S,3S,3'S)-3,3'-Bis(tert-butyl)-2,2',3,3'-tetrahydro-2,2'-bi-1,3-benzoxaphosphole;(2S,2'S,3S,3'S)-3,3'-Di-tert-butyl-2,2',3,3'-tetrahydro-2,2'-bibenzo[d][1,3]oxaphosphole, 97% (>99% ee) (2S,2'S,3S,3'S)-BIBOP
• CAS NO: 1202033-17-7
• Molecular Formula: C22H28O2P2
• Molecular Weight: 386.4
• Mol File: 1202033-17-7.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 495.5±45.0 °C(Predicted)
• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: (2S,2'S,3S,3'S)-BIBOP(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,2'S,3S,3'S)-BIBOP(1202033-17-7)
• EPA Substance Registry System: (2S,2'S,3S,3'S)-BIBOP(1202033-17-7)

Safety Data

• Hazardous Substances Data: 1202033-17-7(Hazardous Substances Data)

Usage

General Description

(2S,2'S,3S,3'S)-BIBOP is a highly potent and selective agonist of the δ-opioid receptor. It is a synthetic compound that belongs to the class of opioid peptides and is structurally related to enkephalins, which are endogenous opioid peptides. BIBOP has been shown to have strong analgesic effects in animal studies, making it a potentially valuable tool for research into pain management and opioid pharmacology. Its unique selectivity for the δ-opioid receptor also makes it a promising candidate for the development of novel analgesic drugs with reduced side effects compared to traditional opioid medications.

Upstream product

• 1202033-09-7 (2S,2'S,3R,3'R)-3,3'-di-tert-butyl-2,2',3,3'-tetrahydro-2,2'-bibenzo[d][1,3]oxaphosphole bisoxide 
• 151-10-0 1,3-Dimethoxybenzene 
• 1202032-93-6 tert-butyl(2,6-dimethoxyphenyl)(iodomethyl)phosphine oxide 
• 1202032-95-8 racemic 3-tert-butyl-2,3-dihydrobenzo[d][1,3]oxaphosphol-4-ol oxide 
• 1202032-97-0 (R)-3-(tert-butyl)-3-oxido-2H-benzo[d][1,3]oxaphosphol-4-yl ((1S,2R,5S)-2-isopropyl-5-methylcyclohexyl) carbonate 
• 1202033-25-7 (R)-3-(tert-butyl)-4-hydroxy-2H-benzo[ d][1,3]oxaphosphole 3-oxide 
• 1202032-99-2 (R)-3-(tert-butyl)-3-oxido-2H-benzo[d][1,3]oxaphosphol-4-yl trifluoromethanesulfonate 
• 1202033-01-9 (R)-3-tert-butyl-2,3-dihydrobenzo[d][1,3]oxaphosphole 3-oxide 
• 1202032-91-4 tert-butyl(2,6-dimethoxyphenyl)(methyl)phosphine oxide 

Relevant articles and documents

NOVEL CHIRAL PHOSPHORUS LIGANDS

The invention relates to a series of novel chiral phosphorus ligands of formulae (Ia) and (Ib): wherein R, 1 - rR> 4 and X are as defined herein. The invention also relates to chiral metal complexes prepared with these chiral phosphorus ligands. The chira